Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001906324-24-000014
Filing Date
2024-02-29
Accepted
2024-02-29 16:40:55
Documents
15
Period of Report
2024-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A qdel-20240214.htm   iXBRL 8-K/A 35274
  Complete submission text file 0001906324-24-000014.txt   190392

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20240214.xsd EX-101.SCH 2249
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20240214_def.xml EX-101.DEF 14433
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20240214_lab.xml EX-101.LAB 28044
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20240214_pre.xml EX-101.PRE 15008
16 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20240214_htm.xml XML 2706
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 8-K/A | Act: 34 | File No.: 001-41409 | Film No.: 24704516
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)